-
Je něco špatně v tomto záznamu ?
Minimally Invasive Aortic Valve Replacement with Sutureless Valves: Results From an International Prospective Registry
M. Glauber, L. Di Bacco, J. Cuenca, R. Di Bartolomeo, M. Baghai, D. Zakova, T. Fischlein, G. Troise, G. Viganò, M. Solinas
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, multicentrická studie, pozorovací studie
PubMed
31875777
DOI
10.1177/1556984519892585
Knihovny.cz E-zdroje
- MeSH
- aortální stenóza chirurgie MeSH
- bezstehová chirurgie metody statistika a číselné údaje MeSH
- bioprotézy MeSH
- chirurgická náhrada chlopně metody statistika a číselné údaje MeSH
- echokardiografie metody MeSH
- kardiochirurgické výkony metody MeSH
- kardiopulmonální bypass statistika a číselné údaje MeSH
- lidé MeSH
- miniinvazivní chirurgické výkony metody MeSH
- prospektivní studie MeSH
- protézy - design trendy MeSH
- registrace MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- srdeční chlopně umělé MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- pozorovací studie MeSH
OBJECTIVE: To report the early and mid-term results of patients who underwent minimally invasive aortic valve replacement (MI-AVR) with a sutureless prosthesis from an international prospective registry. METHODS: Between March 2011 and September 2018, among 957 patients included in the prospective observational SURE-AVR (Sorin Universal REgistry on Aortic Valve Replacement) registry, 480 patients underwent MI-AVR with self-expandable Perceval aortic bioprosthesis (LivaNova PLC, London, UK) in 29 international institutions through either minithoracotomy (n = 266) or ministernotomy (n = 214). Postoperative, follow-up, and echocardiographic outcomes were analyzed for all patients. RESULTS: Patient age was 76.1 ± 7.1 years; 64.4% were female. Median EuroSCORE I was 7.9% (interquartile range [IQR], 4.8 to 10.9). Median cardiopulmonary bypass and cross-clamp times were 81 minutes (IQR 64 to 100) and 51 minutes (IQR 40 to 63). First successful implantation was achieved in 97.9% of cases. Two in-hospital deaths occurred, 1 for noncardiovascular causes and 1 following a disabling stroke. In the early (≤30 days) period, stroke rate was 1.4%. Three early explants were reported: 2 due to nonstructural valve dysfunction (NSVD) and 1 for malpositioning. One mild and 1 moderate paravalvular leak were reported. In 16 patients (3.3%) pacemaker implantation was needed. Mean follow-up was 2.4 years (maximum = 7 years). During follow-up 5 explants were reported, 3 due to endocarditis and 2 due to NSVD. Follow-up stroke rate was 2.5%. Three structural valve deteriorations not requiring reintervention were reported. Five-year survival was 91.45%. CONCLUSIONS: In this large prospective international registry, MI-AVR with Perceval valve confirmed to be safe, reproducible, and effective in an intermediate-risk population, providing excellent clinical recovery both in early and mid-term follow-up.
CHUAC Complexo Hospital Universitario A Coruña Coruna Spain
Fondazione Poliambulanza Brescia Italy
Istituto Clinico Sant'Ambrogio Milan Italy
King's College Hospital London UK
Klinikum Nürnberg Paracelsus Medical University Nuremberg Germany
Ospedale del Cuore G Pasquinucci Massa Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21012828
- 003
- CZ-PrNML
- 005
- 20210507102358.0
- 007
- ta
- 008
- 210420s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1177/1556984519892585 $2 doi
- 035 __
- $a (PubMed)31875777
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Glauber, Mattia $u 46769 Istituto Clinico Sant'Ambrogio, Milan, Italy
- 245 10
- $a Minimally Invasive Aortic Valve Replacement with Sutureless Valves: Results From an International Prospective Registry / $c M. Glauber, L. Di Bacco, J. Cuenca, R. Di Bartolomeo, M. Baghai, D. Zakova, T. Fischlein, G. Troise, G. Viganò, M. Solinas
- 520 9_
- $a OBJECTIVE: To report the early and mid-term results of patients who underwent minimally invasive aortic valve replacement (MI-AVR) with a sutureless prosthesis from an international prospective registry. METHODS: Between March 2011 and September 2018, among 957 patients included in the prospective observational SURE-AVR (Sorin Universal REgistry on Aortic Valve Replacement) registry, 480 patients underwent MI-AVR with self-expandable Perceval aortic bioprosthesis (LivaNova PLC, London, UK) in 29 international institutions through either minithoracotomy (n = 266) or ministernotomy (n = 214). Postoperative, follow-up, and echocardiographic outcomes were analyzed for all patients. RESULTS: Patient age was 76.1 ± 7.1 years; 64.4% were female. Median EuroSCORE I was 7.9% (interquartile range [IQR], 4.8 to 10.9). Median cardiopulmonary bypass and cross-clamp times were 81 minutes (IQR 64 to 100) and 51 minutes (IQR 40 to 63). First successful implantation was achieved in 97.9% of cases. Two in-hospital deaths occurred, 1 for noncardiovascular causes and 1 following a disabling stroke. In the early (≤30 days) period, stroke rate was 1.4%. Three early explants were reported: 2 due to nonstructural valve dysfunction (NSVD) and 1 for malpositioning. One mild and 1 moderate paravalvular leak were reported. In 16 patients (3.3%) pacemaker implantation was needed. Mean follow-up was 2.4 years (maximum = 7 years). During follow-up 5 explants were reported, 3 due to endocarditis and 2 due to NSVD. Follow-up stroke rate was 2.5%. Three structural valve deteriorations not requiring reintervention were reported. Five-year survival was 91.45%. CONCLUSIONS: In this large prospective international registry, MI-AVR with Perceval valve confirmed to be safe, reproducible, and effective in an intermediate-risk population, providing excellent clinical recovery both in early and mid-term follow-up.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a aortální stenóza $x chirurgie $7 D001024
- 650 _2
- $a bioprotézy $7 D001705
- 650 _2
- $a kardiochirurgické výkony $x metody $7 D006348
- 650 _2
- $a kardiopulmonální bypass $x statistika a číselné údaje $7 D002315
- 650 _2
- $a echokardiografie $x metody $7 D004452
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a srdeční chlopně umělé $7 D006350
- 650 _2
- $a chirurgická náhrada chlopně $x metody $x statistika a číselné údaje $7 D019918
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a miniinvazivní chirurgické výkony $x metody $7 D019060
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a protézy - design $x trendy $7 D011474
- 650 _2
- $a registrace $7 D012042
- 650 _2
- $a bezstehová chirurgie $x metody $x statistika a číselné údaje $7 D000071062
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a pozorovací studie $7 D064888
- 700 1_
- $a Di Bacco, Lorenzo $u 46769 Istituto Clinico Sant'Ambrogio, Milan, Italy
- 700 1_
- $a Cuenca, Jose $u 16811 CHUAC - Complexo Hospital Universitario, A Coruña, Coruna, Spain
- 700 1_
- $a Di Bartolomeo, Roberto $u 18508 Policlinico Sant'Orsola, Bologna, Italy
- 700 1_
- $a Baghai, Max $u 111990 King's College Hospital, London, UK
- 700 1_
- $a Zakova, Daniela $u 74797 CKTCH, Brno, Czech Republic
- 700 1_
- $a Fischlein, Theodor $u 9211 Klinikum Nürnberg, Paracelsus Medical University, Nuremberg, Germany
- 700 1_
- $a Troise, Giovanni $u 188700 Fondazione Poliambulanza, Brescia, Italy
- 700 1_
- $a Viganò, Giorgio $u 168099 UMCG, Groningen, The Netherlands
- 700 1_
- $a Solinas, Marco $u 267621 Ospedale del Cuore G. Pasquinucci, Massa, Italy
- 773 0_
- $w MED00181718 $t Innovations (Philadelphia, Pa.) $x 1559-0879 $g Roč. 15, č. 2 (2020), s. 120-130
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31875777 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507102357 $b ABA008
- 999 __
- $a ok $b bmc $g 1651072 $s 1133207
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 15 $c 2 $d 120-130 $e 20191226 $i 1559-0879 $m Innovations $n Innovations (Phila) $x MED00181718
- LZP __
- $a Pubmed-20210420